Changqiang Zhou Appointed as Party Secretary of Qionghai City, Hainan Province, Promoted to Deputy Departmental LevelPresident Anura Kumara Dissanayake said that threatening officials or disregarding their opinions in the presence of the media is not a part of his Government’s policy. He said that the new approach to transformation involves fostering self-discipline and accountability and invited all Government officials to unite in this effort to create a positive change. The President was addressing the staff of the Ministry of Finance, Planning and Economic Development on Friday, November 22, after assuming duties as its Minister. The President was warmly welcomed by the staff on his arrival at the Ministry. He expressed his heartfelt appreciation for the contribution by the Ministry officials in navigating the country through the recent economic crisis and stressed the importance of a continued collective effort, adding that everyone’s support is essential in achieving future success. The President acknowledged the public’s lack of trust in revenue-generating departments and said that changing this perception would be challenging. He said that all officials now have the opportunity to rectify any negative impressions and rebuild public confidence in their roles under the new Government. President Dissanayake said that while the country has a history of judging Government officials based on preconceived notions during political transitions, moving forward, their contributions will be the sole benchmark for evaluation. He said that if any unfair treatment or obstacles arise in the course of their duties, he would stand firmly by them in their defence. The President said that if the Government fails to meet the aspirations of the people it could lead to citizens losing hope in envisioning a prosperous future. He said that Government officials must dedicate themselves to building a Government that fulfils the people’s aspirations. Deputy Ministers, Prof. Anil Jayantha Fernando, Dr. Harshana Suriyapperuma and the Secretary to the President Dr. Nandika Sanath Kumanayake and Treasury Secretary Mahinda Siriwardena, and senior officials of the Ministry of Finance were present.

In addition to the new playable characters, the update also brings a host of new weapons, armor, and gear for players to discover and master. From powerful mythical weapons infused with ancient magic to intricately designed armor sets that offer unique stat boosts and bonuses, the new gear options available in the game are sure to provide players with the tools they need to customize their gameplay experience and tailor their playstyle to suit their preferences.Novak Djokovic breaks his silence on tennis doping scandals - and reveals what he really thinks of Nick Kyrgios's tough stance

Moment of silence for former President Jimmy Carter held before the Falcons-Commanders game

In conclusion, the expulsion of Wu Yingjie from the CPC serves as a cautionary tale for all officials who are tempted to abuse their power for personal gain. It underscores the Party's commitment to maintaining a clean and efficient government that serves the best interests of the Chinese people. Let this be a lesson to all that corruption will not be tolerated, and those who engage in such behavior will face the consequences of their actions.In conclusion, as Salzburg prepares to face Paris, the defenders know that they must be brave in their approach, but they also understand the need for strong defensive resilience. By uniting these qualities on the field, they aim to make a statement in their upcoming match – proving that they can stand tall against the best teams in Europe.

Patriots safety Jabrill Peppers, accused of domestic violence, cleared to practice and playLANDOVER, Md. (AP) — with a moment of silence before the Atlanta Falcons’ game at the Washington Commanders on Sunday night, hours after the 39th president of the United States in Plains, Georgia. Beyond being a Georgia native who led the country from the White House less than 8 miles (12 kilometers) away during his time in office from 1977-81, Carter was the first president to host the NFL's Super Bowl champions there when he welcomed the Pittsburgh Steelers in 1980. released by the team before kickoff said he was deeply saddened by the loss of his dear friend and mentor, calling Carter “a great American, a proud Georgian and an inspirational global humanitarian.” “He lived his life with great civic responsibility and took it upon himself to be the change he wished to see amongst other,” Blank said, recalling meeting Carter at The Home Depot. “President Carter’s kind and uniting spirit touched so many lives. He was a man of deep faith, and did everything with principal and grace, doing things the right way for the right reasons." ___ AP NFL:

A poll by Ipsos shows Milanović leading with over 50% of the vote, with his main challenger Dragan Primorac, trailing far behind with 22%. Croatia's incumbent President Zoran Milanović has a sweeping lead in Sunday's election and could win the five-year presidency in the first round, according to an exit poll released immediately after the voting. The poll by Ipsos and released by state television HRT showed Milanović winning over 50% of the votes, while his main challenger Dragan Primorac, the candidate for the conservative HDZ ruling party trailed far behind at 22%. Milanović thanked voters in a post on social networks. The first official results are yet to be published. Pre-election polls predicted that the two would face off in the second round on 12 January, as none of all eight presidential election contenders were projected to get more than 50% of the vote. Left-leaning Milanović is an outspoken critic of Western military support for Ukraine in its war against Russia. He is often compared to Donald Trump for his combative style of communication with political opponents. The most popular politician in Croatia, 58-year-old Milanović has served as prime minister in the past. Populist in style, he has been a fierce critic of current Prime Minister Andrej Plenković and continuous sparring between the two has lately marked Croatia's political scene. Plenković has sought to portray the vote as one about Croatia's future in the EU and NATO. He has labelled Milanović "pro-Russian" and a threat to Croatia's international standing. "The difference between him and Milanović is quite simple: Milanović is leading us East, Primorac is leading us West," he said. Though the presidency is largely ceremonial in Croatia, an elected president holds political authority and acts as the supreme military commander. Milanović has criticised NATO and EU support for Ukraine and has often insisted that Croatia should not take sides, saying the country should stay away from global disputes, despite being a member of both alliances. Milanović has also blocked Croatia's participation in a NATO-led training mission for Ukraine, declaring that "no Croatian soldier will take part in somebody else's war." His main rival in the election, Primorac, has stated that "Croatia's place is in the West, not the East." His presidency bid, however, has been marred by a high-level corruption case that landed Croatia's health minister in jail last month and featured prominently in pre-election debates. During the election campaign, Primorac has sought to portray himself as a unifier and Milanović as divisive. "Today is an extremely important day,” Primorac said after casting his ballot. "Croatia is going forward into the future. Croatia needs unity, Croatia needs its global positioning, and above all Croatia needs peaceful life." Trailing a distant third in the pre-election polls is Marija Selak Raspudić, a conservative independent candidate. She focused her election campaign on the economic troubles of ordinary citizens, corruption and issues such as population decline in the country of some 3.8 million. Sunday's presidential election is Croatia's third vote this year, following a parliamentary election in April and the European Parliament balloting in June.

LAG-3 Antagonist Pipeline Drugs and Companies Insight Report, 2024 Updates: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments 11-25-2024 08:29 PM CET | Health & Medicine Press release from: DelveIinsight Business Research (Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, LAG-3 Antagonist pipeline constitutes 20+ key companies continuously working towards developing 20+ LAG-3 Antagonist treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "LAG-3 Antagonist Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the LAG-3 Antagonist Market. The LAG-3 Antagonist Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details. Some of the key takeaways from the LAG-3 Antagonist Pipeline Report: https://www.delveinsight.com/sample-request/lag-3-antagonist-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr •Companies across the globe are diligently working toward developing novel LAG-3 Antagonist treatment therapies with a considerable amount of success over the years. •LAG-3 Antagonist companies working in the treatment market are MacroGenics, Novartis, and others, are developing therapies for the LAG-3 Antagonist treatment •Emerging LAG-3 Antagonist therapies in the different phases of clinical trials are- Tebotelimab, LAG525, and others are expected to have a significant impact on the LAG-3 Antagonist market in the coming years. •In May 2024, Regeneron Pharmaceuticals developed Fianlimab, an intravenously administered monoclonal antibody that targets the LAG-3 immune checkpoint receptor on T cells. This therapy was created using Regeneron's proprietary Velocimmune platform. LAG-3 Antagonist Overview LAG-3 Antagonist refers to a type of immunotherapy that targets the Lymphocyte Activation Gene-3 (LAG-3) protein, an immune checkpoint receptor found on T cells. LAG-3 plays a key role in regulating immune responses by suppressing T cell activity, helping tumors evade immune detection. Antagonists of LAG-3 block this suppression, enhancing the immune system's ability to recognize and attack cancer cells. These therapies are being explored in combination with other immune checkpoint inhibitors, such as PD-1/PD-L1 inhibitors, to improve efficacy in treating various cancers. LAG-3 antagonists are an emerging focus in oncology research with promising therapeutic potential. Get a Free Sample PDF Report to know more about LAG-3 Antagonist Pipeline Therapeutic Assessment- https://www.delveinsight.com/report-store/lag-3-antagonist-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Emerging LAG-3 Antagonist Drugs Under Different Phases of Clinical Development Include: •Tebotelimab: MacroGenics •LAG525: Novartis LAG-3 Antagonist Route of Administration LAG-3 Antagonist pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as •Oral •Parenteral •Intravenous •Subcutaneous •Topical LAG-3 Antagonist Molecule Type LAG-3 Antagonist Products have been categorized under various Molecule types, such as •Monoclonal Antibody •Peptides •Polymer •Small molecule •Gene therapy LAG-3 Antagonist Pipeline Therapeutics Assessment •LAG-3 Antagonist Assessment by Product Type •LAG-3 Antagonist By Stage and Product Type •LAG-3 Antagonist Assessment by Route of Administration •LAG-3 Antagonist By Stage and Route of Administration •LAG-3 Antagonist Assessment by Molecule Type •LAG-3 Antagonist by Stage and Molecule Type DelveInsight's LAG-3 Antagonist Report covers around 20+ products under different phases of clinical development like •Late-stage products (Phase III) •Mid-stage products (Phase II) •Early-stage product (Phase I) •Pre-clinical and Discovery stage candidates •Discontinued & Inactive candidates •Route of Administration Further LAG-3 Antagonist product details are provided in the report. Download the LAG-3 Antagonist pipeline report to learn more about the emerging LAG-3 Antagonist therapies at: https://www.delveinsight.com/sample-request/lag-3-antagonist-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Some of the key companies in the LAG-3 Antagonist Therapeutics Market include: Key companies developing therapies for LAG-3 Antagonist are - MacroGenics, Novartis, Merck Sharp & Dohme, Crescendo Biologics, F-star Therapeutics, MICROBIO Group, Bristol-Myers Squibb, Ono Pharmaceuticals, Symphogen, Avacta, Abeome Corporation, and others. LAG-3 Antagonist Pipeline Analysis: The LAG-3 Antagonist pipeline report provides insights into •The report provides detailed insights about companies that are developing therapies for the treatment of LAG-3 Antagonist with aggregate therapies developed by each company for the same. •It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for LAG-3 Antagonist Treatment. •LAG-3 Antagonist key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects. •LAG-3 Antagonist Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type. •Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the LAG-3 Antagonist market. The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc. Download Sample PDF Report to know more about LAG-3 Antagonist drugs and therapies- https://www.delveinsight.com/sample-request/lag-3-antagonist-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr LAG-3 Antagonist Pipeline Market Drivers •Rising Cancer Prevalence, Advancements in Immunotherapy, Collaborations and Partnerships, Promising Clinical Trial Results, FDA Breakthrough Designations, are some of the important factors that are fueling the LAG-3 Antagonist Market. LAG-3 Antagonist Pipeline Market Barriers •However, High Development Costs, Complexity in Clinical Trials, Competitive Landscape, Regulatory Hurdles, Limited Awareness, and other factors are creating obstacles in the LAG-3 Antagonist Market growth. Scope of LAG-3 Antagonist Pipeline Drug Insight •Coverage: Global •Key LAG-3 Antagonist Companies: MacroGenics, Novartis, and others •Key LAG-3 Antagonist Therapies: Tebotelimab, LAG525, and others •LAG-3 Antagonist Therapeutic Assessment: LAG-3 Antagonist current marketed and LAG-3 Antagonist emerging therapies •LAG-3 Antagonist Market Dynamics: LAG-3 Antagonist market drivers and LAG-3 Antagonist market barriers Request for Sample PDF Report for LAG-3 Antagonist Pipeline Assessment and clinical trials- https://www.delveinsight.com/sample-request/lag-3-antagonist-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Table of Contents 1. LAG-3 Antagonist Report Introduction 2. LAG-3 Antagonist Executive Summary 3. LAG-3 Antagonist Overview 4. LAG-3 Antagonist- Analytical Perspective In-depth Commercial Assessment 5. LAG-3 Antagonist Pipeline Therapeutics 6. LAG-3 Antagonist Late Stage Products (Phase II/III) 7. LAG-3 Antagonist Mid Stage Products (Phase II) 8. LAG-3 Antagonist Early Stage Products (Phase I) 9. LAG-3 Antagonist Preclinical Stage Products 10. LAG-3 Antagonist Therapeutics Assessment 11. LAG-3 Antagonist Inactive Products 12. Company-University Collaborations (Licensing/Partnering) Analysis 13. LAG-3 Antagonist Key Companies 14. LAG-3 Antagonist Key Products 15. LAG-3 Antagonist Unmet Needs 16 . LAG-3 Antagonist Market Drivers and Barriers 17. LAG-3 Antagonist Future Perspectives and Conclusion 18. LAG-3 Antagonist Analyst Views 19. Appendix 20. About DelveInsight Latest Reports: •Pd-1 & Pdl1 Market: https://www.delveinsight.com/report-store/pd-1-and-pd-l1-inhibitors-competitive-landscape •Cervical Dysplasia Market: https://www.delveinsight.com/report-store/cervical-dysplasia-market-insights •Hypogonadism Market: https://www.delveinsight.com/report-store/hypogonadism-market •Acoustic Neuroma Market: https://www.delveinsight.com/report-store/acoustic-neuroma-market •Non-hodgkin's Lymphoma Market: https://www.delveinsight.com/report-store/non-hodgkins-lymphoma-market •Substance Use Disorder Market: https://www.delveinsight.com/report-store/substance-use-disorder-market •Transcatheter Heart Valve Replacement Devices Market: https://www.delveinsight.com/report-store/transcatheter-aortic-valve-replacement-market •Bone Neoplasms Market: https://www.delveinsight.com/blog/bone-cancer-treatment-market •Peak Flow Meters Market: https://www.delveinsight.com/report-store/peak-flow-meters-market Contact Us: Gaurav Bora gbora@delveinsight.com +14699457679 Healthcare Consulting https://www.delveinsight.com/consulting-services About DelveInsight DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach. This release was published on openPR.Bills clinch the AFC's No. 2 seed with a 40-14 rout of the undisciplined JetsYouth work with legislators to brainstorm policies for preventing violent extremism

AP News Summary at 5:08 p.m. ESTPerhaps it's time for a serious conversation about the well-being of managers in the Premier League. While the competitiveness and excitement of English football are undoubtedly thrilling for fans, we must also consider the toll it takes on those working behind the scenes. Burnout and exhaustion should not be normalized or dismissed as part of the job. The mental and physical health of managers should be a top priority, as they play a crucial role in shaping the future of the sport.

As the exciting inaugural LaWa Cup approaches, fans of table tennis around the world are eagerly anticipating the competition, which promises to showcase some of the sport's brightest talents. Among them, Chinese table tennis star Chen Meng has recently shared her thoughts and predictions for the upcoming tournament in a video that has captivated fans and generated even more excitement.Beyond being a Georgia native who led the country from the White House less than 8 miles (12 kilometers) away during his time in office from 1977-81, Carter was the first president to host the NFL's Super Bowl champions there when he welcomed the Pittsburgh Steelers in 1980. Falcons owner Arthur Blank in a statement released by the team before kickoff said he was deeply saddened by the loss of his dear friend and mentor, calling Carter “a great American, a proud Georgian and an inspirational global humanitarian.” “He lived his life with great civic responsibility and took it upon himself to be the change he wished to see amongst other,” Blank said, recalling meeting Carter at The Home Depot. “President Carter’s kind and uniting spirit touched so many lives. He was a man of deep faith, and did everything with principal and grace, doing things the right way for the right reasons." AP NFL: https://apnews.com/hub/nfl

The latest rankings in the Chinese Basketball Association have sent shockwaves through the league as Beijing suffered a surprising loss, relinquishing their position at the top of the standings. Meanwhile, the underdog team from Shandong pulled off a major upset, and Qingdao sealed a thrilling victory against Jiangsu in a last-second thriller. The intense competition and unpredictable outcomes have left fans and analysts on the edge of their seats, as the battle for supremacy continues to unfold.Dick's Sporting Goods shares rise on analyst optimism ahead of results

Are you not entertained?: Mississippi win shows Florida's Billy Napier has turned the corner